Research and Markets: Philips Medical Systems: A Medical Device Company Intelligence Report Providing a Full Review of the Company's Activities

Business Wire, Sept 15, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/37d730/philips_medical_sy) has announced the addition of the "Philips Medical Systems: Medical Device Company Intelligence Report" company profile to their offering.

Medical Device Company Intelligence Reports provide a full review of the companys activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

Headquartered in Best, the Netherlands, and Andover, MA, USA, Philips Healthcare is part of the multinational electronics giant, Royal Philips Electronics Group. Formerly called Philips Medical Systems, the new Healthcare operating sector was created at the beginning of 2008 when Philips realigned its business activities into three separate companies - Healthcare, Lighting and Consumer Lifestyle - with each being responsible for the management of its businesses worldwide. Philips Healthcare brings together the former Medical Systems division and Home Healthcare Solutions - formerly the Consumer Healthcare Solutions business - which has been transferred from Innovation & Emerging Businesses.

Philips Healthcare offers a broad portfolio of medical systems. The company's product line includes X-ray, ultrasound, magnetic resonance, computed tomography, nuclear medicine and PET imaging technologies, as well as radiation oncology systems, patient monitoring, information management and resuscitation products. Philips Healthcare also offers a wide range of services to support its businesses. Philips Healthcare is a leader in many of the markets in which it participates and in 2007 had sales of EUR 6.7 billion (approximately US$9.9 billion).

A core part of Philips healthcare strategy is to achieve a leading position in the high growth sector of home healthcare. Given the unsustainably high healthcare costs in many markets and increased emphasis on both efficiency and patient comfort, there is a gradual shift towards diagnosing, treating and monitoring patients in their homes rather than in hospitals. Demand for home healthcare is also growing due to the increasing number of elderly people and the rising incidence of chronic diseases. Philips had already made a number of successful acquisitions in the home healthcare area, including Lifeline Systems, Health Watch and Raytel Cardiac Services, but recently executed its biggest acquisition to date with the purchase of Respironics for US$5.1 billion. Respironics is the global leader in the treatment of obstructive sleep apnoea (OSA), a sleep disorder characterised by the repeated cessation of breathing during sleep. Additionally, the company has a leading position in non-invasive ventilation and has recently introduced new home oxygen technologies to serve the needs of respiratory-impaired patients in the home. The Respironics acquisition creates for Philips a Healthcare sector with sales of over EUR 7 billion going forward and global leadership positions in areas such as cardiac care, acute care, and now also home healthcare. The acquisition also affords Philips a more diversified portfolio in its healthcare business and less reliance on its US$4 billion imaging systems business which has been affected by softening in the key North American market, principally due to cuts in reimbursement, and which is not expected to show any real recovery in the near term.

Key Topics Covered:

EXECUTIVE SUMMARY

OVERVIEW

STRATEGIC FOCUS

PRODUCT OVERVIEW

IMAGING SYSTEMS

CARDIAC CARE

INFANT MANAGEMENT

PATIENT MONITORING

ACUTE POINT OF CARE AND HOME VENTILATION

REMOTE PATIENT MANAGEMENT

RESEARCH AND DEVELOPMENT

INTERNATIONAL ACTIVITIES

APPENDICES

APPENDIX 1 - FINANCIAL INDICATORS

FINANCIAL INDICATORS - PHILIPS GROUP

APPENDIX 2 - KEY CORPORATE EVENTS

APPENDIX 3 - MERGERS AND ACQUISITIONS

APPENDIX 4 - JOINT VENTURES

APPENDIX 5 - MINORITY INVESTMENTS

APPENDIX 6 - DIVESTITURES

APPENDIX 7 - AGREEMENTS8

Companies Mentioned:

- ADAC Laboratories

- Agilent Technologies' Healthcare Solutions Group

- Amirsys

- Analogic

- Anesthesia Recording

- Ascent Profit

- Aspect Medical Systems

- ATL Ultrasound2

- Atos Origin

- BG Medicine

- Bioscan

- BrainLAB

- Capital Health

- CardioDynamics

- CardioLogica

- Civco Medical Instruments (Roper Industries)

- Cozart

- Dixtal Biomedica e Tecnologia

- Dubai Health Authority

- EDDA Technology

- Emergin

- EP MedSystems

- Epic Systems

- Fukuda Denshi

- GeneGo

- HealthCare Products Group

- HealthTrust Purchasing Group

- Heartstream

- Inova Health System

- Intermagnetics General

- ISG Technologies

- Kaiser Permanente

- Kereos

- Laerdal

- LiDCO

- LifeGuard Medical Solutions

- Marconi Medical Systems

- Masimo

- MedAssets

- Medcare

- Medical Center of Central Georgia